Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Clinical trial NCT07392892 · RECRUITING

Trial details

NCT number: NCT07392892
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma Metastatic Gastric Cancer Gastroesophageal Junction Cancer Esophageal Adenocarcinoma

Start date: 2026-05-14
Primary completion: 2031-07-22
Enrollment: 840

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.